Unexpected Positive Patch Test Reactions to Disperse Blue 106 and 124 in Patients Sensitized to Sulphites, Likely due to Cross‐Reactivity
O.A. is investigator, consultant, and/or speaker for Leo Pharma, AbbVie, Sanofi-Genzyme, L'Oréal/La Roche Posay, Novartis, Incyte, Amgen, Janssen-Cilag, and Bioderma/NAOS. The other authors have no conflicts to declare. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Olivier Aerts (ORCID: https://orcid.org/0000-0002-0076-2887)
- An E. Goossens (ORCID: https://orcid.org/0000-0002-9805-3439)
- Silada Kanokrungsee (ORCID: https://orcid.org/0000-0003-0837-2725)
- Ella Dendooven (ORCID: https://orcid.org/0000-0002-3489-8010)
- Julie van Reusel (ORCID: https://orcid.org/0009-0006-3785-4538)
Institutions
- Siriraj Hospital (TH)
- University of Antwerp (BE)
- Mahidol University (TH)
- Antwerp University Hospital (BE)
- KU Leuven (BE)
Publication Details
- Journal
- Contact Dermatitis
- Published
- 2026-10-06
- DOI
- https://doi.org/10.1111/cod.70262
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 0.00